维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Huober"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	PhaseⅢStudy of GemcitabinePlus Docetaxel Compared With Capecitabine Plus Docetaxel for An-thracycline Pretreated Patients With Metastatic Breast Cancer显示文摘	Chan S Romieu G Huober Jens	2009	Journal of Clinical Oncology2009，27，11：	1
2	Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study显示文摘	Huober J yon Minckwitz G Denkert C	2010	Breast Cancer Res Treat2010，124，1：	1
3	Diagnostic and prognostic use of bone turnover markers显示文摘	Joerger M Huober J	2012	Recent Results Cancer Res2012，192，：	1
4	Phase Ⅲ study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer显示文摘	Chan S Romieu G Huober J	2009	J Clin Oncol2009，27，11：	1
5	Phase III study of gemcitabine plus docetaxel compared with capeeitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer显示文摘	Chan S Romieu G Huober J	2009	J Clin Oncol2009，27，11：	1
6	Phase Ⅲ Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer显示文摘	Stephen Clan Gilles Romieu Jens Huober	2009	J Clin Oncol2009，27，7：	1
7	Symptoms of endocrine treatment and outcome in the BIG 1-98 study 显示文摘	Huober J Cole BF Rabaglio M	2014	Breast Cancer ResTreat2014，143，1：	1
8	Symptoms of endocrine treatment and outcome in the BIG 1-98 study显示文摘	Huober J Cole BF Rabaglio M	2014	Breast Cancer Res Treat2014，143，1：	1
9	Diagnostic and prognostic use of bone turnover markers显示文摘	Joerger M Huober J	2012	Recent Results Cancer Res2012，192，：	1
10	The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer显示文摘	Huober J Meyer A Wagner U	2002	J Cancer Res Clin Oncol2002，128，3：	1
11	Prognosis of medullary breast cancer:analysis of 13 international breast cancer study group (1BCSG) trials显示文摘	Huober J Gelber S Goldhirsch A		0，，11：	1
12	Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracyeline2Pretreated Patients With Metastatic Breast Cancer 显示文摘	Chart S Romieu G Huober Jens	2009	Journal of Clinical Oncology2009，27，11：	1
13	The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer显示文摘	Huober J Meyer A Wagner U	2002	Cancer Res Clin Oncol2002，128，：	1
14	Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase Ⅰ/Ⅱ study显示文摘	Schneeweiss A Huober J Sinn HP	2004	Eur J Cancer2004，40，16：	1
15	Phase III study of gemcitabine plus docetaxel compared with capecit- abine plus docetaxel for anthracycline-pretreated pa- tients with metastatic breast cancer显示文摘	Chan S Romieu G Huober J	2009	J Clin Oncol2009，27，11：	1
16	Neoadjuvant chemotherapy in operable breast cancer with docetaxel, doxorubicin, and cyclophosphamide (TAC) or TAC followed by vinorelbine and capecitabine (NX): final results and analysis of markers predicting response to treatment显示文摘	Huober J yon Minckwitz G Denkert C	2009	J Clin Oncol2009，，：	1
17	Diagnostic and prognostic use of bone turnover markers 显示文摘	Joerger M Huober J	2012	Recent Results Cancer Res2012，192，3：	1
18	Diagnostic and prognostic use of bone turnover markers显示文摘	Joerger M Huober J	2012	Recent Results Cancer Res2012，192，：	1
19	The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer显示文摘	Huober J Meyer A Wagner U	2002	Cancer Res Clin Oncol2002，128，：	1
20	Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive,hormone-receptor-positive metastatic breast cancer-results of the e LEc TRA trial显示文摘	Huober J Fasching PA Barsoum M	2012	Breast2012，21，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示